Allergen-derived T-cell peptide immunotherapy in allergic asthmatic individuals is associated with induction of CD4+ IFN-gamma+/CD4+CD25+ T cells and enhanced expression of TGF-beta and Notch-1 ligands at sites of cutaneous allergen challenge